Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Rockwell Medical



) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.7%. By the end of trading, Rockwell Medical fell $0.29 (-1.9%) to $15.30 on light volume. Throughout the day, 935,928 shares of Rockwell Medical exchanged hands as compared to its average daily volume of 2,620,700 shares. The stock ranged in price between $15.00-$15.85 after having opened the day at $15.59 as compared to the previous trading day's close of $15.59. Other companies within the Health Care sector that declined today were:

Mast Therapeutics



), down 38.6%,

CombiMatrix Corporation



), down 14.1%,

Conatus Pharmaceuticals



), down 11.9% and

Amarin Corporation



), down 11.5%.

Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. Rockwell Medical has a market cap of $600.0 million and is part of the drugs industry. Shares are up 86.3% year to date as of the close of trading on Thursday. Currently there are 2 analysts that rate Rockwell Medical a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates

Rockwell Medical

as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we also find weaknesses including poor profit margins, weak operating cash flow and generally higher debt management risk.

On the positive front,

Ariad Pharmaceuticals

TST Recommends



), up 35.5%,

Galena Biopharma



), up 14.6%,




), up 14.6% and

Cardiome Pharma Corporation



), up 14.4% , were all gainers within the health care sector with

Regeneron Pharmaceuticals



) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR



) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care




STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.